Abstract
Background
Insulin has been recently shown to decrease mortality and prevent the incidence of multi-organ failure in critically ill patients. The molecular mechanisms by which insulin improves survival have not been defined. The purpose of the present study was to determine the effect of insulin therapy on the systemic inflammatory response. In vivo we determined the effect of insulin therapy on the inflammatory cascade, which was induced by thermal injury.
Materials and Methods
Thermally injured rats (30% TBSA) were randomly divided into two groups to receive either saline (n = 28) or insulin (n = 28). Our outcome measures encompassed the effect of insulin on pro-inflammatory cytokines, anti-inflammatory cytokines, and hepatic signal transcription factor mRNA expression.
Results
Insulin significantly decreased dose dependently serum pro-inflammatory cytokines IL-1β at 1, 5, and 7 days, IL-6 at 1 day, MIF at 5 and 7 days, and TNF at 1 and 2 days after injury when compared with controls (p < 0.05). Insulin increased anti-inflammatory cytokines IL-2 and IL-4 at 5 and 7 days after trauma, and IL-10 at 2, 5 and 7 days after trauma when compared with controls (p < 0.05). Pro-inflammatory signal transcription factors STAT-5 and C/EBP-β mRNA were significantly decreased 1 and 2 days posttrauma; insulin increased anti-inflammatory signal transcription factor mRNA expression of SOCS-3 and RANTES 7 days after the injury (p < 0.05).
Conclusions
Our data provide insight that insulin attenuates the inflammatory response by decreasing the proinflammatory and increasing the anti-inflammatory cascade, thereby restoring systemic homeostasis, which has been shown critical for organ function and survival in critically ill patients.
Similar content being viewed by others
References
Andersson U, Wang H, Palmblad K, et al. (2000) High mobility group 1 protein (HMG-1) stimulates pro-inflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192: 565–570.
Tracey KJ, Beutler B, Lowry SF, et al. (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234: 470–474.
Dinarello CA. (1994) The interleukin-1 family: 10 years of discovery. FASEB J. 8: 1314–1325.
de Waal Malefyt R, Abrams J, Bennett B. (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulation role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209–1220.
Kusske AM, Rongione AJ, Reber HA. (1996) Cytokines and acute pancreatitis. Gastroenterology 110: 639–642.
Trautwein C, Rakemann T, Pietrangelo A, et al. (1996) C/EBP-beta/LAP controls down-regulation of albumin gene transcription during liver regeneration. J. Biol. Chem. 271: 22262–22270.
Niehof M, Streetz K, Rakemann T, et al. (2001) Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPbeta promoter suggests a new mechanism of transcriptional regulation by STAT3. J. Biol. Chem. 276: 9016–9027.
Gilpin DA, Hsieh CC, Kuninger DT, Herndon DN, Papaconstantinou J. (1996) Effect of thermal injury on the expression of transcription factors that regulate acute phase response genes: the response of C/EBPα, C/EBPβ, and C/EBPδ to thermal injury. Surgery 119: 674–683.
Ogle CK, Kong F, Guo X, et al. (2000) The effect of burn injury on suppressors of cytokine signalling. Shock 14: 392–399.
Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E. (2000) SOCS-3 is an insulin-induced negative regulator of insulin signalling. J. Biol. Chem. 275: 15985–15991.
Nelson PJ, Kim HT, Manning WC, Goralski TJ, Krensky AM. (1993) Genomic organization and transcriptional regulation of the RANTES chemokine gene. J. Immunol. 151: 2601–2612.
Van den Berghe G, Wouters P, Weekers F, et al. (2001) Intensive insulin therapy in critically ill patients. N. Engl. J. Med. 345: 1359–1367.
Jeschke MG, Herndon DN, Barrow RE. (2000) Insulin-like growth factor-I plus insulin-like growth factor binding protein-3 affects the hepatic acute phase response and hepatic morphology in thermally injured rats. Ann. Surg. 231: 408–416.
Herndon DN, Wilmore DW, Mason AD Jr, Pruitt BA Jr. (1978) Development and analysis of a small animal model simulating the human postburn hypermetabolic response. J. Surg. Res 25: 394–403.
Chomczynski P, Sacchi N. (1987) Single step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156–165.
Rennie MJ. (1985) Muscle protein turnover and wasting due to injury and disease. Br. Med. Bull. 41: 257–264.
Takala J, Ruokonen E, Webster NR, et al. (1999) Increased mortality associated with growth hormone treatment in critically ill patients. N. Engl. J. Med. 341: 785–792.
van den Berghe G, de Zegher F, Veldhuis JD. (1997) The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. J. Clin. Endocrinol. Metab. 82: 590–599.
Frost RA, Lang CH, Gelato MC. Transient exposure of human myoblasts to tumor necrosis factor-α inhibits serum and insulin-like growth factor-I stimulated protein synthesis. Endocrinology 138: 4153–4159.
Timmins AC, Cotterill AM, Hughes SC. (1996) Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin like growth factors binding proteins, and induction of an insulinlike growth factor binding protein 3 protease. Crit. Care Med. 24: 1460–1466.
Tracey KJ, Fong Y, Hesse DG, et al. (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330: 662–664.
Pruitt JH, Copeland EM, Moldawer LL. (1999) Interleukin-1 and interleukin-1 antagonism in sepsis systemic inflammatory response syndrome and septic shock. Shock 3: 235–251.
Alexander HR, Doherty GM, Buresh CM. (1991) A recombinant human receptor antagonist to interleukin-1 improves survival after lethal endotoxemia in mice. J. Exp. Med. 173: 1029–1032.
Taniguchi T, Koido Y, Aiboshi J, Tamashita T, Suzaki S, Kurokawa A. (1999) Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit. Care Med. 27: 1262–1264.
Jeschke MG, Barrow RE, Suzuki F, Herndon DN. (in press) IGF-I/IGFBP-3 equilibrates ratios of pro- to anti-inflammatory cytokines which are predictors for organ function in severely burned pediatric patients. Mol. Med.
Kile BT, Alexander WS. (2001) The suppressors of cytokine signaling (SOCS). Cell. Mol. Life Sci. 58: 1627–1635.
Takagi K, Suzuki F, Barrow RE, Wolf SE, Kobayashi M, Herndon DN. (1997) Recombinant human growth hormone improves immune function and survival in burned mice infected with herpes simplex virus type 1. J. Surg. Res. 69: 166–170.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jeschke, M.G., Einspanier, R., Klein, D. et al. Insulin Attenuates the Systemic Inflammatory Response to Thermal Trauma. Mol Med 8, 443–450 (2002). https://doi.org/10.1007/BF03402024
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03402024